Shanghai GenTech Co

Shanghai GenTech Co Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Shanghai GenTech Co (688596.SS) as of Oct 27, 2026 is -6.23. In the previous year, Net Debt to Free Cash Flow Ratio was 6.66 — a change of -193.51% (lower).

Net Debt/FCF

-6.23

YoY

-193.51%

Last updated:

Net Debt to Free Cash Flow Ratio of Shanghai GenTech Co is 2025 -6.23 . Net Debt to Free Cash Flow Ratio of Shanghai GenTech Co was 2024 6.66 . It decreases by -193.51% lower compared to the previous year.

The Shanghai GenTech Co Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
0.47 CNY
Jan 1, 2019
-2.35 CNY
Jan 1, 2020
9.46 CNY
Jan 1, 2021
2.43 CNY
Jan 1, 2022
0.46 CNY
Jan 1, 2023
0.61 CNY
Jan 1, 2024
6.66 CNY
Jan 1, 2025
-6.23 CNY
The Shanghai GenTech Co Net Debt/FCF history
YEARNet Debt/FCFYoY
-6.23-193.51%
6.66+988.36%
0.61+31.77%
0.46-80.86%
2.43-74.34%
9.46-502.36%
-2.35-602.55%
0.47-232.94%
-0.35-158.50%
0.60+69.29%
0.36-21.35%
0.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai GenTech Co Stock analysis

What does Shanghai GenTech Co do? Shanghai GenTech Co., Ltd. generates revenue through three core business segments. The gas chemical supply system segment offers special gas tanks, shunt boxes, liquid source conveying equipment, and pharmaceutical liquid mixing units for integrated IC, FPD, and micro-electronic systems. The high-purity specialty gases segment sells arsine, phosphorane, silane, and mixed gases primarily to semiconductor and optical fiber communication industries. The clean plant supporting system segment provides clean room air conditioning, air filtration, interior decoration, process cooling water, clean compressed air, and vacuum systems for semiconductor and pharmaceutical manufacturing facilities. These solutions target semiconductor, optical fiber communication, and pharmaceutical sectors as key customers. The company's products are designed for process materials and equipment needs across integrated systems in IC, FPD, optoelectronic, PV, optical communication, and micro-electronic industries. Gas chemical supply systems support semiconductor and pharmaceutical manufacturing with specialized equipment like liquid source conveying and pharmaceutical liquid mixing units. High-purity specialty gases such as arsine and silane are critical for semiconductor fabrication processes. Clean plant systems ensure controlled environments for sensitive manufacturing operations in high-tech industries. Shanghai GenTech's customer base includes semiconductor manufacturers requiring gas supply systems and high-purity gases for chip production. Optical fiber communication companies utilize the clean room and air filtration systems for their manufacturing facilities. Pharmaceutical firms purchase pharmaceutical liquid mixing units and clean plant systems for sterile production environments. These industries represent the primary market segments for the company's integrated solutions. Shanghai GenTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai GenTech Co stock

Net Debt to Free Cash Flow Ratio of Shanghai GenTech Co is -6.23 in 2025.

Net Debt to Free Cash Flow Ratio of Shanghai GenTech Co changed from 6.66 to -6.23, representing a -193.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Shanghai GenTech Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Shanghai GenTech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Shanghai GenTech Co

All Key Metrics — Shanghai GenTech Co